Featured Fireside Chat

28 October 2008 Past Event

In April of this year, Takeda Pharmaceutical, Japan’s largest drug company purchased Millennium Pharmaceuticals, one of the earliest American genomics companies for nearly $9 billion providing Takeda an entry into the cancer-drug market. During this off-the-record discussion, topics will include:

  • Important criteria each company sought in a strategic partner
  • Communicating effectively through cultural differences
  • Lessons learned during the due diligence process
  • Approach for successful integration of the two companies

Presenters included:

  • Gabor Garai, Co-Chair, Life Sciences Industry Team, Foley
  • Dr. Daniel Curran, Vice President, Corporate Development, Millennium Pharmaceuticals Inc.
  • Catherine Sazdanoff, Vice President, Global Licensing, Takeda Pharmaceuticals North America, Inc.